Vertebral fractures in Gaucher disease type I: Data from the French "observatoire" on Gaucher disease (FROG)

Osteoporosis International

Volumn 22, Issue 4, 2011, Pages 1255-1261

  Javier, R M ^a   Hachulla, E ^b   Rose, C ^c   Gressin, V ^d   Cherin P ^e   Noel E ^f   De Roux Serratrice, C ^g   Dobbelaere, D ^b   Hartmann, A ^e   Jaussaud, R ^h   Clerson, P ⁱ   Grosbois, B ^j   Roux, C ^k  

^a HÔPITAL DE HAUTEPIERRE   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c HÔPITAL SAINT VINCENT DE PAUL   (France)

^d Actelion Pharmaceuticals France   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f HÔPITAL CIVIL   (France)

^g TIMONE HOSPITAL   (France)

^h SERVICE DE DERMATOLOGIE   (France)

ⁱ Orgametrie   (France)

^j SERVICE DE RHUMATOLOGIE   (France)

^k UNIVERSITÉ PARIS DESCARTES   (France)

more..

Author keywords

Bone; Fracture; Gaucher disease; Osteopenia; Osteoporosis

Indexed keywords

AGED; ARTICLE; BONE NECROSIS; CLINICAL EXAMINATION; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GAUCHER DISEASE; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; OSTEOPENIA; OSTEOPOROSIS; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; VERTEBRA FRACTURE;

ADULT; AGED; BONE DISEASES, METABOLIC; COHORT STUDIES; FEMALE; FRANCE; GAUCHER DISEASE; HUMANS; MALE; MIDDLE AGED; OSTEOPOROTIC FRACTURES; PREVALENCE; SPINAL FRACTURES; SPLENECTOMY;

EID: 79953311866     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-010-1342-y     Document Type: Article

References (34)

1. J Charrow HC Andersson P Kaplan, et al. 2000 The Gaucher Registry: demographics and disease characteristics of 1, 698 patients with Gaucher disease Arch Int Med 160 2835 2843 1:STN:280:DC%2BD3cvnvVelsQ%3D%3D
2. P Kaplan HC Andersson KA Kacena JD Yee 2006 The clinical and demographic characteristics of nonneuronopathic Gaucher disease in 887 children at diagnosis Arch Pediatr Adolesc Med 160 603 608 16754822 (Pubitemid 43854401)
3. DW Stowens SL Teitelbaum AJ Kahn JA Barranger 1985 Skeletal complications of Gaucher disease Medicine (Baltimore) 64 310 322 1:STN:280: DyaL2M3psFeksQ%3D%3D (Pubitemid 16224046)
4. V Barak M Acker B Nisman, et al. 1999 Cytokines in Gaucher's disease Eur Cytokine Netw 10 205 210 10400826 1:CAS:528:DyaK1MXlsFWiurk%3D (Pubitemid 29332776)
5. NW Barton RO Brady JM Dambrosia, et al. 1991 Replacement therapy for inherited enzyme deficiency-macrophage-targeted glucocerebrosidase for Gaucher's disease N Engl J Med 324 1464 1470 2023606 1:STN:280:DyaK3M3hvVyitg%3D%3D
6. PM Campeau M Rafei MN Boivin Y Sun GA Grabowski J Galipeau 2009 Characterization of Gaucher disease bone marrow mesenchymal stromal cells reveals an altered inflammatory secretome Blood 114 3181 3190 19587377 1:CAS:528:DC%2BD1MXhtlShtbjK
7. J Charrow B Dulisse GA Grabowski NJ Weinreb 2007 The effect of enzyme replacement therapy on bone crisis and bone pain in patients with type 1 Gaucher disease Clin Genet 71 205 211 17309642 1:STN:280:DC%2BD2s7htVaruw%3D%3D (Pubitemid 46322658)
8. RF DeMayo AH Haims MC McRae R Yang PK Mistry 2008 Correlation of MRI-based bone marrow burden score with genotype and spleen status in Gaucher's disease AJR Am J Roentgenol 191 115 123 18562733 (Pubitemid 351955212)
9. RJ Wenstrup M Roca-Espiau NJ Weinreb B Bembi 2002 Skeletal aspects of Gaucher disease: a review Br J Radiol 75 suppl A2 A12 12036828
10. R Jaussaud 2006 The French 'observatoire' on Gaucher's disease Eur J Int Med 17 Suppl 1 S2 S8
11. HK Genant CY Wu C vanKuijk M Nevitt 1993 Vertebral fracture assessment using a semi-quantitative technique J Bone Miner Res 8 1137 1148 8237484 1:STN:280:DyaK2c%2FlsFyhuw%3D%3D (Pubitemid 23261108)
12. P Giraldo M Pocovi J Perez-Calvo D Rubio-Felix M Giralt 2000 Report of the Spanish Gaucher's Disease Registry: clinical and genetic characteristics Heamatologica 85 792 799 1:STN:280:DC%2BD3M%2FksFyksg%3D%3D
13. B Bembi G Ciana E Mengel MR Terk C Martini RJ Wenstrup 2002 Bone complications in children with Gaucher disease Br J Radiol 75 Suppl 1 A37 A44 12036831
14. NJ Weinreb J Charrow HC Andersson, et al. 2002 Effectiveness of enzyme replacement therapy in 1, 028 patients with type 1 Gaucher disease after 2-5 years of treatment. A report from the Gaucher registry Am J Med 113 112 119 12133749 1:CAS:528:DC%2BD38XlsVKru74%3D (Pubitemid 34804747)
15. H Andersson H Andersson P Kaplan K Kacena J Yee 2008 Eight-year clinical outcomes of long-term enzyme replacement therapy for 884 children with Gaucher disease type 1 Pediatrics 122 1182 1190 19047232
16. A Zimran A Kay T Gelbart, et al. 1992 Gaucher disease. Clinical, laboratory, radiologic and genetic features of 53 patients Medicine 71 337 353 1435229 1:STN:280:DyaK3s%2FmtF2kug%3D%3D
17. J Stirnemann 2006 Etude clinique de la cohorte française de patients atteints de la maladie de Gaucher Rev Med Interne 27 S18 S21 16644396
18. N Belmatoug T Billette de Villemeur 1995 Skeletal response to enzyme replacement therapy for type 1 Gaucher disease: a preliminary report of the French experience Semin Hematol 32 Suppl 1 33 38
19. M Roca J Mota P Alfonso M Pocoví P Giraldo 2007 S-MRI score: a simple method for assessing bone marrow involvement in Gaucher disease Eur J Radiol 62 132 137 17161930 1:STN:280:DC%2BD2s7mvFOltA%3D%3D (Pubitemid 46413626)
20. K Katz S Sabato G Horev IJ Cohen Z Yosipovitch 1993 Spinal involvement in children and adolescents with Gaucher disease Spine 18 332 335 8475432 1:STN:280:DyaK3s3jsFWisQ%3D%3D (Pubitemid 23086741)
21. MS Kocher JE Hall 2000 Surgical management of spinal involvement in children and adolescents with Gaucher's disease J Pediatr Orthop 20 383 388 10823610 1:STN:280:DC%2BD3czps1ygsQ%3D%3D (Pubitemid 30252759)
22. L Wiesner O Niggemeyer R Kothe L Meiss 2003 Severe pathologic compression of three consecutive vertebrae in Gaucher disease: a case report and review of the literature Eur Spine J 12 97 99 12592553 1:STN:280:DC%2BD3s%2FnvF2itA%3D%3D (Pubitemid 36286837)
23. ME Ruff LD Weis JR Kean 1984 Acute thoracic kyphosis in Gaucher's disease. A case report Spine 9 835 837 6396845 1:STN:280:DyaL2M7kt1GjsQ%3D%3D (Pubitemid 15158681)
24. SC Hill CC Parker RO Brady NW Barton 1993 MRI of multiple platyspondyly in Gaucher disease: response to enzyme replacement therapy J Comput Assist Tomogr 17 806 809 8370839 1:STN:280:DyaK3szotFWgtg%3D%3D (Pubitemid 23277275)
25. B Grosbois C Rose V Gressin, et al. 2009 Gaucher disease and monoclonal gammopathy: a report of 17 cases and impact of therapy Blood Cells Mol Dis 43 138 139 19427246
26. J Goldblatt P Keet D Dall 1987 Spinal cord decompression for Gaucher's disease Neurosurgery 21 227 230 3658134 1:STN:280:DyaL1c%2FhsVGgsA%3D%3D (Pubitemid 17131124)
27. KB Sims GM Pastores NJ Weinreb, et al. 2008 Improvement of bone disease by imiglucerase (Cerezyme) therapy in patients with skeletal manifestations of type 1 Gaucher disease: results of a 48-month longitudinal cohort study Clin Genet 73 430 440 18312448 1:STN:280:DC%2BD1c3jvFCmsw%3D%3D (Pubitemid 351517258)
28. M de Fost CJ van Noesel JM Aerts M Maas RG Pöll CE Hollak 2008 Persistent bone disease in adult type 1 Gaucher disease despite increasing doses of enzyme replacement therapy Haematologica 93 1119 1120 18519519 (Pubitemid 351957043)
29. RJ Wenstrup L Bailey GA Grabowski, et al. 2004 Gaucher disease: alendronate disodium improves bone mineral density in adults receiving enzyme therapy Blood 104 1253 1257 15010365 1:CAS:528:DC%2BD2cXnt1ekur0%3D (Pubitemid 39166496)
30. GM Pastores D Elstein M Hrebícek A Zimran 2007 Effect of miglustat on bone disease in adults with type 1 Gaucher disease: a pooled analysis of three multinational, open-label studies Clin Ther 29 1645 1654 17919546 1:CAS:528:DC%2BD2sXhtFyjt7jK (Pubitemid 47494543)
31. E Lebel A Dweck AJ Foldes, et al. 2004 Bone density changes with enzyme therapy for Gaucher disease J Bone Miner Metab 22 597 601 15490271 (Pubitemid 39517881)
32. RJ Wenstrup KA Kacena P Kaplan, et al. 2007 Effect of enzyme replacement therapy with imiglucerase on BMD in type 1 Gaucher disease J Bone Miner Res 22 119 126 17032149 1:CAS:528:DC%2BD2sXhtVWnur0%3D (Pubitemid 46032604)
33. N Weinreb J Barranger S Packman, et al. 2007 Imiglucerase (Cerezyme) improves quality of life in patients with skeletal manifestations of Gaucher disease Clin Genet 71 576 588 17539908 1:STN:280:DC%2BD2szislynuw%3D%3D (Pubitemid 46831953)
34. GM Pastores NJ Weinreb H Aerts, et al. 2004 Therapeutic goals in the treatment of Gaucher disease Semin Hematol 41 Suppl 5 4 14 15468045 (Pubitemid 39311677)